Home NAFDAC raises concerns over fake COVID-19 AstraZeneca vaccine

NAFDAC raises concerns over fake COVID-19 AstraZeneca vaccine

Share
Share

The National Agency for Food and Drug Administration and Control (NAFDAC) has urged Nigerians to check for the original label on the Astrazeneca vaccine being administered on them.

In a statement issued yesterday, the agency said the warning was imperative to ensure people did not risk being vaccinated with the fake Astrazeneca vaccine.

NAFDAC’s Director-General, Prof. Mojisola Adeyeye, who signed the statement explained that the original Oxford Astrazeneca University (AZOU) vaccine, had been contracted to India’s world largest vaccine manufacturer, Serum Institute of India (SIIPL), to produce in large quantity.

AZOU gave the license of its vaccine to Serum Institute of India PVT Ltd, (SIIPL), to manufacture this vaccine at a commercial scale. SIIPL is the largest vaccine manufacturer in the world and the company got the license by signing the manufacturing agreement.

“SIIPL gave the vaccine the trade name COVISHIELD, it is the result of a cooperation and a technology transfer from AstraZeneca – University of Oxford to SIIPL.

“SIIPL is now the world’s largest vaccine manufacturer by number of doses produced and sold globally.

“More than 1.5 billion doses, which include Polio vaccine, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella,” she said.

Adeyeye added that the vaccines manufactured by SIIPL were accredited by the World Health Organisation (WHO), and were being used in about 170 countries across the globe in their national immunisation programme.

She added that both COVISHIELD manufactured by SIIPL and COVID-19 vaccine Astrazeneca, manufactured by Astrazeneca/Oxford University vaccine are the same vaccine.

According to Adeyeye, ChAdOx1 nCoV- 19 coronavirus vaccines (Recombinant), COVISHIELD, was granted Emergency Use Listing (EUL) by the World Health Organisation on Feb.15, and that it was one of the listed vaccines under the COVAX Facility.

(Thisday)

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Member

Don't Miss

Recapitalisation Without Transformation is a Risk Nigeria Cannot Afford

By Blaise Udunze In barely two weeks, Nigeria’s banking sector will once again be at a historic turning point. As the deadline for...

What the US–Iran War Means for Everyday Nigerians

By Chioma Obinagwam On a Tuesday morning in Ajegunle, a low-income neighbourhood in Lagos, Mama Bisola Balogun stared at the empty cooking gas...

Related Articles

Recapitalisation Without Transformation is a Risk Nigeria Cannot Afford

By Blaise Udunze In barely two weeks, Nigeria’s banking sector will once...

What the US–Iran War Means for Everyday Nigerians

By Chioma Obinagwam On a Tuesday morning in Ajegunle, a low-income neighbourhood...

The price has changed again: How Nigeria’s inflation crisis is dismantling lives

By Chioma Obinagwam It is 5:47 in the morning at Mile 12...

NGX Group, IFC and WIMBIZ drive women’s financial inclusion at IWD 2026 ceremony

By Chioma Obinagwam Nigerian Exchange Group Plc (NGX Group), in partnership with...

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny